The Korean Journal of Internal Medicine10.3904/kjim.2010.25.2.1682010252168The Contribution of Abdominal Obesity and Dyslipidemia to Metabolic Syndrome in Psychiatric PatientsSung-Hwan Kim, Kiwon Kim, Mi Hyang Kwak, Hak Jin Kim, Hong-Sup Kim, Ki Hoon Han,,
Diabetes & Metabolism10.1016/s1262-3636(03)72788-820032946S53-6S61Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetesJ.P. Després,
Obesity10.1038/oby.2009.381200917n3sS1-S2Abdominal Obesity, Insulin Resistance, and the Metabolic Syndrome: Contribution of Physical Activity/ExerciseRobert Ross, Jean-Pierre Després
Metabolic Syndrome10.1007/978-3-319-11251-0_302016525-540Dyslipidemia in ObesityDick C. Chan, Jing Pang, Gerald F. Watts
Obesity10.1038/oby.2006.2812006142S41S-49SMetabolic Syndrome: Focus on DyslipidemiaHenry N. Ginsberg, Yuan-Li Zhang, Antonio Hernandez-Ono,
Nutrition in the Prevention and Treatment of Abdominal Obesity10.1016/b978-0-12-816093-0.00001-x20193-18Sleep, Abdominal Obesity, and Metabolic SyndromeChris I. Ardern, Thirumagal Kanagasabai,
Diabetes & Metabolic Syndrome: Clinical Research & Reviews10.1016/j.dsx.2017.04.024201711S675-S678Sugar-sweetened beverages consumption is associated with abdominal obesity risk in diabetic patientsRazieh Anari, Reza Amani, Masoud Veissi,
Metabolic Syndrome and Related Disorders10.1089/met.2008.0040200864289-297Metabolic Syndrome and C-Reactive Protein in American Adults: The Impact of Abdominal ObesityIke S. Okosun
Metabolic Syndrome10.1007/978-3-319-12125-3_30-120151-18Dyslipidemia in ObesityDick C. Chan, Jing Pang, Gerald F. Watts
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy10.2147/dmso.s1158552017Volume 10333-343Diabetes and dyslipidemia: characterizing lipoprotein metabolismGerald Tomkin, Daphne Owens,